Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.138ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.138EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.138EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.138ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.138ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.379EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AZ.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AZ.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.270EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.270EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.270ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.270ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.270EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.270EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.270ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.270ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.227EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.227EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.227ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.227ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.227EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.227EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.227ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.227ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
U.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
U.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
U.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
U.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
U.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
U.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
U.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.253EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.253EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.253ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used